[go: up one dir, main page]

ITMI930182A0 - Composizioni farmaceutiche comprendenti materiale spugnoso costituito da derivati esterei dell'acido ialuronico in associazione con altre sostanze farmacologicamente attive - Google Patents

Composizioni farmaceutiche comprendenti materiale spugnoso costituito da derivati esterei dell'acido ialuronico in associazione con altre sostanze farmacologicamente attive

Info

Publication number
ITMI930182A0
ITMI930182A0 ITMI930182A ITMI930182A ITMI930182A0 IT MI930182 A0 ITMI930182 A0 IT MI930182A0 IT MI930182 A ITMI930182 A IT MI930182A IT MI930182 A ITMI930182 A IT MI930182A IT MI930182 A0 ITMI930182 A0 IT MI930182A0
Authority
IT
Italy
Prior art keywords
spongous
estere
association
derivatives
pharmaceutical compositions
Prior art date
Application number
ITMI930182A
Other languages
English (en)
Inventor
Lanfranco Callegaro
Original Assignee
Lanfranco Callegaro
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lanfranco Callegaro filed Critical Lanfranco Callegaro
Priority to ITMI930182A priority Critical patent/IT1263144B/it
Publication of ITMI930182A0 publication Critical patent/ITMI930182A0/it
Priority to EP94906201A priority patent/EP0682534A1/en
Priority to KR1019950703218A priority patent/KR960700766A/ko
Priority to PCT/EP1994/000294 priority patent/WO1994017840A1/en
Priority to CA002155518A priority patent/CA2155518A1/en
Priority to AU60014/94A priority patent/AU6001494A/en
Priority to JP6517622A priority patent/JPH08506497A/ja
Publication of ITMI930182A1 publication Critical patent/ITMI930182A1/it
Application granted granted Critical
Publication of IT1263144B publication Critical patent/IT1263144B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/28—Polysaccharides or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/425—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ITMI930182A 1993-02-04 1993-02-04 Composizioni farmaceutiche comprendenti materiale spugnoso costituito da derivati esterei dell'acido ialuronico in associazione con altre sostanze farmacologicamente attive IT1263144B (it)

Priority Applications (7)

Application Number Priority Date Filing Date Title
ITMI930182A IT1263144B (it) 1993-02-04 1993-02-04 Composizioni farmaceutiche comprendenti materiale spugnoso costituito da derivati esterei dell'acido ialuronico in associazione con altre sostanze farmacologicamente attive
EP94906201A EP0682534A1 (en) 1993-02-04 1994-02-02 Pharmaceutical compositions comprising a spongy material consisting of ester derivatives of hyaluronic acid combined with other pharmacologically active substances
KR1019950703218A KR960700766A (ko) 1993-02-04 1994-02-02 히알루론산의 에스테르유도체가 다른 약학적으로 유효한 물질과 결합된 해면재로 구성된 약제조성물
PCT/EP1994/000294 WO1994017840A1 (en) 1993-02-04 1994-02-02 Pharmaceutical compositions comprising a spongy material consisting of ester derivatives of hyaluronic acid combined with other pharmacologically active substances
CA002155518A CA2155518A1 (en) 1993-02-04 1994-02-02 Pharmaceutical compositions comprising a spongy material consisting of ester derivatives of hyarulonic acid combined with other pharmacologically active substances
AU60014/94A AU6001494A (en) 1993-02-04 1994-02-02 Pharmaceutical compositions comprising a spongy material consisting of ester derivatives of hyaluronic acid combined with other pharmacologically active substances
JP6517622A JPH08506497A (ja) 1993-02-04 1994-02-02 他の薬物学的活性物質と組み合わせたヒアルロン酸のエステル誘導体からなるスポンジ状材料を含んでなる薬学的組成物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI930182A IT1263144B (it) 1993-02-04 1993-02-04 Composizioni farmaceutiche comprendenti materiale spugnoso costituito da derivati esterei dell'acido ialuronico in associazione con altre sostanze farmacologicamente attive

Publications (3)

Publication Number Publication Date
ITMI930182A0 true ITMI930182A0 (it) 1993-02-04
ITMI930182A1 ITMI930182A1 (it) 1994-08-04
IT1263144B IT1263144B (it) 1996-08-01

Family

ID=11364858

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI930182A IT1263144B (it) 1993-02-04 1993-02-04 Composizioni farmaceutiche comprendenti materiale spugnoso costituito da derivati esterei dell'acido ialuronico in associazione con altre sostanze farmacologicamente attive

Country Status (7)

Country Link
EP (1) EP0682534A1 (it)
JP (1) JPH08506497A (it)
KR (1) KR960700766A (it)
AU (1) AU6001494A (it)
CA (1) CA2155518A1 (it)
IT (1) IT1263144B (it)
WO (1) WO1994017840A1 (it)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0907721A1 (en) * 1996-05-28 1999-04-14 Brown University Research Foundation Hyaluronan based biodegradable scaffolds for tissue repair
US6596703B1 (en) 1997-07-11 2003-07-22 Jagotec Ag Promotion of wound healing utilizing steroids having reduced deteriorous systemic side effects typical of glucocorticoids, mineralocorticoids and sex steroids
US6872819B1 (en) * 1998-05-27 2005-03-29 Fidia Advanced Biopolymers S.R.L. Biomaterials containing hyaluronic acid derivatives in the form of three-dimensional structures free from cellular components or products thereof for the in vivo regeneration of tissue cells
CN1774272A (zh) * 2000-12-07 2006-05-17 株式会社日本组织工程 组织再生用基材、移植用材料及其制备方法
CA2435491C (en) 2001-01-31 2010-02-02 Seikagaku Corporation Crosslinked polysaccharide sponge
US7238677B2 (en) 2003-03-28 2007-07-03 Kimberly-Clark Worldwide, Inc. Prevention of urogenital infections
JP4959557B2 (ja) * 2004-07-09 2012-06-27 フェロサン メディカル デバイシーズ エイ／エス ヒアルロン酸含有止血合成剤
JP4754532B2 (ja) * 2007-07-09 2011-08-24 生化学工業株式会社 ヒアルロン酸オリゴ糖を有効成分とする治療剤
US8642831B2 (en) 2008-02-29 2014-02-04 Ferrosan Medical Devices A/S Device for promotion of hemostasis and/or wound healing
CA2865349C (en) 2012-03-06 2021-07-06 Ferrosan Medical Devices A/S Pressurized container containing haemostatic paste
EP2825216B1 (en) 2012-06-12 2015-08-19 Ferrosan Medical Devices A/S Dry haemostatic composition
AU2014283170B2 (en) 2013-06-21 2017-11-02 Ferrosan Medical Devices A/S Vacuum expanded dry composition and syringe for retaining same
RU2678592C1 (ru) 2013-12-11 2019-01-30 Ферросан Медикал Дивайсиз А/С Сухая композиция, содержащая компонент, улучшающий экструзию
BR112017007466B1 (pt) 2014-10-13 2021-03-02 Ferrosan Medical Devices A/S método para preparar uma composição seca, método para reconstituir a composição seca, pasta, composição seca, recipiente, kit homeostático, e, uso de uma composição seca
BR112017013565B1 (pt) 2014-12-24 2021-12-28 Ferrosan Medical Devices A/S Seringa para retenção e mistura de primeira e segunda substâncias
RU2717356C2 (ru) 2015-07-03 2020-03-23 Ферросан Медикал Дивайсиз А/С Шприц для удерживания вакуума в состоянии хранения
KR20210008479A (ko) 2018-05-09 2021-01-22 훼로산 메디칼 디바이스 에이/에스 지혈 조성물을 제조하는 방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1229075B (it) * 1985-04-05 1991-07-17 Fidia Farmaceutici Medicamenti per uso topico, ottenuti tramite l'impiego dell'acido ialuronico
US4851521A (en) * 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid
IT1219587B (it) * 1988-05-13 1990-05-18 Fidia Farmaceutici Polisaccaridi carbossiilici autoreticolati
IT1248934B (it) * 1990-06-01 1995-02-11 Fidia Spa Membrane forate biocompatibili,processi per la loro preparazione,loro impiego come supporto per la crescita in vitro di cellule epiteliali, pelli artificiali cosi' ottenute e loro impiego nei trapianti di pelle
IT1247472B (it) * 1991-05-31 1994-12-17 Fidia Spa Processo per la preparazione di microsfere contenenti componenti biologicamente attivi.
IT1251151B (it) * 1991-08-05 1995-05-04 Fidia Spa Materiale spugnoso essenzialmente costituito da acido ialuronico,o suoi derivati
IT1260154B (it) * 1992-07-03 1996-03-28 Lanfranco Callegaro Acido ialuronico e suoi derivati in polimeri interpenetranti (ipn)

Also Published As

Publication number Publication date
AU6001494A (en) 1994-08-29
ITMI930182A1 (it) 1994-08-04
KR960700766A (ko) 1996-02-24
IT1263144B (it) 1996-08-01
WO1994017840A1 (en) 1994-08-18
JPH08506497A (ja) 1996-07-16
EP0682534A1 (en) 1995-11-22
CA2155518A1 (en) 1994-08-18

Similar Documents

Publication Publication Date Title
ITMI930182A0 (it) Composizioni farmaceutiche comprendenti materiale spugnoso costituito da derivati esterei dell'acido ialuronico in associazione con altre sostanze farmacologicamente attive
ITMI912207A0 (it) Materiale spugnoso essenzialmente costituito da acido ialuronico o suoi derivati
ITPD910229A0 (it) Tessuto non tessuto essenzialmente costituito da derivati dell'acido laluronico
HUT57202A (en) Process for producing new pharmaceutically active 5-fluoro-2-///4-/cyclopropyl-methoxy/-2-pyridinyl/-methyl-sulfonyl/-1h-benzimidazol and pharmaceutical compositions containing them
PT862575E (pt) Novos derivados de geranilgeranilo processo para a sua preparacao e composicoes farmaceuticas relacionadas
ITRM910189A0 (it) Derivati amminoacilici e oligopeptidici dell'allopurinolo dotati di attivita' immunostimolante e composizioni farmaceutiche che li contengono
AU652784B2 (en) Combination of hyaluronic acid with medicinal ingredient and production thereof
ITMI911059A1 (it) Acido metiltauroursodesossicolico e suoi derivati terapeuticamente attivi procedimento per la sua preparazione e composizioni farmaceutiche che lo contengono
IT9048102A0 (it) Derivati oligopeptidici dell'ipoxantina dotati di attivita' immunomodulante e composizioni farmaceutiche che li contengono
IT1231342B (it) Derivati peptidici farmacologicamente attivi e preparazioni farmaceutiche che li contengono
IT1231723B (it) Derivati dell'acido piroglutammico, loro preparazioni e composizioni farmaceutiche che li contengono
IT1210582B (it) Derivati di acido 4-fenil-4-ossobuten-2-oico dotati di proprieta'farmacologiche e composizioni farmaceutiche che li contengono
IT1219567B (it) Derivati di forskolina,loro procedimento ed intermedi di preparazione,loro applicazione in qualita' di medicamenti e composizioni farmaceutiche che li contengono
ITMI910581A1 (it) Derivati dell'acido 5-fenil-1h-pirazol-4-propionico, loro preparazione e loro impiego come medicamenti
ITFI920134A1 (it) Derivati 7-neopentil xantinici, loro preparazione e composizioni farmaceutiche che li contengono
ITMI930013A0 (it) Derivati dell'acido 2-azetidinone -1-solfonico , loro preparazione e composizioni farmaceutiche che li contengono
IT9019494A0 (it) Derivati insaturi di acidi biliari, loro preparazione e composizione farmaceutiche che li contengono
IT1271404B (it) Derivati ossimici dell'acido formilfenilacetamido-cefalosporanico
ITRM910829A0 (it) Derivati dell'ipoxantina dotati di attivita' immunomodulante e composizioni farmaceutiche che li contengono
ITRM920760A1 (it) Derivati amminoacilici e oligopeptidici dell'ipoxantina b-sostituita dotati di attivita' immunostimolante e composizioni farmaceutiche che li contengono.
ITMI913433A1 (it) Derivati dell'acido 2-azetidinone-1-solfonico, loro preparazione e composizioni farmaceutiche che li contengono
ITMI913511A0 (it) Derivati dell'eserolina ad attivita' anticolinesterasica,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
ITMI913398A0 (it) Derivati dell'eserolina ad attivita' anticolinesterasica procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
IT1219695B (it) Derivati ad azione batteriostatica e antitossige loro preparazione e composizioni farmaceutiche
ITMI951210A0 (it) Nuovi derivati dell'alfa-tocoferolo e composizioni farmaceutiche che li contengono quali principi attivi

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970227